CREDIT SUISSE AG/ - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$217,393
-59.5%
63,939
-12.5%
0.00%
-100.0%
Q2 2023$537,211
+38.3%
73,090
+94.9%
0.00%
Q1 2023$388,552
-12.9%
37,505
-0.7%
0.00%
Q4 2022$446,254
-45.8%
37,786
-3.7%
0.00%
-100.0%
Q3 2022$824,000
-40.8%
39,236
-12.4%
0.00%0.0%
Q2 2022$1,391,000
-32.2%
44,808
-10.3%
0.00%
-50.0%
Q1 2022$2,051,000
-3.3%
49,939
+2.4%
0.00%
+100.0%
Q4 2021$2,120,000
-13.8%
48,786
-0.6%
0.00%0.0%
Q3 2021$2,458,000
-11.7%
49,074
+12.8%
0.00%0.0%
Q2 2021$2,784,000
-34.7%
43,503
-5.1%
0.00%
-50.0%
Q1 2021$4,262,000
-38.4%
45,863
-40.6%
0.00%
-33.3%
Q4 2020$6,924,000
+17.7%
77,268
+35.7%
0.00%
-25.0%
Q3 2020$5,883,000
+4.1%
56,945
-20.3%
0.00%0.0%
Q2 2020$5,652,000
+70.5%
71,472
+24.8%
0.00%
+33.3%
Q1 2020$3,314,000
-7.8%
57,288
-14.1%
0.00%0.0%
Q4 2019$3,596,000
+110.8%
66,667
+104.3%
0.00%
+200.0%
Q3 2019$1,706,000
+20.5%
32,638
+11.3%
0.00%0.0%
Q2 2019$1,416,000
-45.5%
29,334
-43.0%
0.00%
-50.0%
Q1 2019$2,600,000
-42.1%
51,463
-32.0%
0.00%
-60.0%
Q4 2018$4,487,000
+99.5%
75,698
+121.6%
0.01%
+150.0%
Q3 2018$2,249,000
-5.1%
34,153
-27.3%
0.00%0.0%
Q2 2018$2,371,000
+31.4%
46,978
+37.1%
0.00%0.0%
Q1 2018$1,804,000
+28.7%
34,263
+13.6%
0.00%
+100.0%
Q4 2017$1,402,000
-20.7%
30,164
-30.9%
0.00%
-50.0%
Q3 2017$1,767,000
+74.4%
43,681
+46.1%
0.00%
+100.0%
Q2 2017$1,013,000
-48.5%
29,893
-55.9%
0.00%
-50.0%
Q1 2017$1,968,000
+20.5%
67,798
+36.4%
0.00%0.0%
Q4 2016$1,633,000
+2.5%
49,720
-1.6%
0.00%0.0%
Q3 2016$1,593,000
+10.0%
50,523
-1.9%
0.00%0.0%
Q2 2016$1,448,000
+49.4%
51,484
+93.4%
0.00%
+100.0%
Q1 2016$969,000
+93.4%
26,624
+112.7%
0.00%0.0%
Q4 2015$501,000
-10.5%
12,518
-36.2%
0.00%0.0%
Q3 2015$560,000
-60.0%
19,633
-53.8%
0.00%0.0%
Q2 2015$1,400,000
+42.3%
42,476
+24.1%
0.00%0.0%
Q1 2015$984,000
+1.3%
34,216
-4.1%
0.00%0.0%
Q4 2014$971,000
-25.2%
35,672
-41.4%
0.00%0.0%
Q3 2014$1,298,000
-31.6%
60,905
-28.0%
0.00%
-50.0%
Q2 2014$1,898,000
-27.8%
84,541
-18.8%
0.00%
-33.3%
Q1 2014$2,630,000
+19.1%
104,109
+8.4%
0.00%
+50.0%
Q4 2013$2,208,000
+170.6%
96,046
+124.2%
0.00%
+100.0%
Q3 2013$816,000
-36.3%
42,839
-53.2%
0.00%0.0%
Q1 2013$1,281,00091,6090.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders